7 interventions graded Proven in humans.
ApoB (Apolipoprotein B)
One of the few longevity-community favorites that is genuinely well-founded: causality is established by genetics and trials, and ApoB meaningfully improves risk assessment over LDL-C, especially in metabolically abnormal people. Not hype. The main gap is that guideline adoption and outcome-defined ApoB targets are still catching up to the mechanistic case.
GLP-1 Receptor Agonists (Semaglutide, Tirzepatide)
Genuinely transformative cardiometabolic drugs with real mortality-relevant benefit in people with excess weight, but they are not validated longevity agents, and muscle loss plus lack of aging-specific outcome data temper the 'anti-aging miracle' framing. Powerful for the right person, not a geroprotector for the lean and healthy.
Mediterranean Diet
One of the very few longevity interventions with randomized hard-outcome evidence, not just biomarkers. It is genuinely evidence-based and low-risk. The main caveat is that PREDIMED tested it against a low-fat comparator in a Spanish high-risk population, so effect sizes may not transfer identically everywhere.
Resistance Training
One of the most underrated, best-evidenced longevity interventions. Preserving muscle and strength directly protects against the frailty-disability-death cascade. No supplement or drug rivals it for maintaining functional independence, yet it gets a fraction of the attention of unproven therapies.
SGLT2 Inhibitors (Canagliflozin, Empagliflozin, Dapagliflozin)
Real, hard-endpoint mortality benefit in sick populations (heart/kidney disease) and a striking male-mouse lifespan result, but the sex-specific animal effect and lack of any healthy-human aging trial mean the leap to 'longevity drug for the well' is unearned.
Statins (in a Longevity Context)
Genuinely life-saving for cardiovascular risk, and preventing the #1 killer buys years, but that is targeted disease prevention, not aging modulation. Calling statins a 'longevity drug' conflates two different things: they lengthen life by stopping heart attacks, not by slowing the aging process.
Zone 2 & VO2max Cardio
VO2max is arguably the most powerful modifiable predictor of longevity, and improving it is unambiguously beneficial. The specific Zone-2 framing is popular and physiologically reasonable, but the mortality data are observational (fit people differ from unfit people) and no trial proves a Zone-2 label outperforms simply doing plenty of aerobic exercise plus some high intensity.